AprilBio is Biotechnology in South Korea that focus on bio-better therapeutics business. Founded in 2013. They cover business area such as operator, long-act bio-well therapeutic and antibody drug, human Fab antibody fragment, serum albumin, human monoclonal, desire antigen-bind specificity, medical professional, hepatitis B and c virus.
2013
( 11 years old in 2024 )
Bio-better Therapeutics
-
Room 602, Building B, Medical and Bioscience College
Gangwon University1, Gangwon-daehak-gil (Hyoja-dong)
Chuncheon, Gangwon-do 24341
South Korea
Private
operatorlong-act bio-well therapeutic and antibody drughuman Fab antibody fragmentserum albuminhuman monoclonaldesire antigen-bind specificitymedical professionalhepatitis B and c virus
* We use standard office opening hours in near AprilBio's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
AprilBio is Biotechnology business from South Korea that founded in 2013 (11 years old in 2024), AprilBio business is focusing on Bio-better Therapeutics.
AprilBio headquarter office and corporate office address is located in Room 602, Building B, Medical and Bioscience College Gangwon University1, Gangwon-daehak-gil (Hyoja-dong) Chuncheon, Gangwon-do 24341 South Korea.
AprilBio was founded in South Korea.
In 2024, AprilBio is currently focus on bio-better therapeutics sector.
Above is snippet of Google Trends for "bio-better therapeutics" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with AprilBio, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
